摘要:
The present invention refers to the use of cationic liposomal preparations for the treatment or diagnosis of rheumatoid arthritis or related disorders.
摘要:
The present invention relates to parvovirus mutated structural proteins comprising insertions of mimotopes of a HER2, compositions, multimeric structures, medicaments and vaccines comprising the same, nucleic acids, expression cassettes, constructs, vectors and cells comprising the nucleic acids, methods of preparing the structural proteins and methods of inducing a B-cell response or of treating a HER2-related disease.
摘要:
A display device has a plurality of display units (D.sub.1, D.sub.2 . . . D.sub.n), each display unit consisting of a number of multiplex-operated display sections, each of which has a plurality of display elements which can be simultaneously but independently switched and each of which has a respective display driver (for example, T.sub.1), and a circuit arrangement for controlling the display device. The circuit arrangement includes a memory (M) in which the information to be output via the display device is stored, a microcontroller (MC) which has at least one synchronous serial interface (2) and a DMA controller (3) for transferring data intended for each time the same display section of the display units (D.sub.1, D.sub.2 . . . D.sub.n) from the memory to the interface, a shift register arrangement (S.sub.1, S.sub.2 . . . S.sub.n) which is connected to the serial interface (2) and which has a parallel output, and storage members (L.sub.1, L.sub.2 . . . L.sub.n) which are connected to the parallel output of the shift register arrangement for periodically taking up the contents of the shift register arrangement and for controlling the display drivers (T.sub.1, T.sub.2 . . . T.sub.n).
摘要:
The present invention concerns lyophilized pharmaceutical preparations of G-CSF that contain maltose, raffinose, sucrose, trehalose or amino sugar as stabilizing agents. In additon the invention concerns a process for the production of stabilized lyophilisates as well as the use of maltose, raffinose, sucrose, trehalose or amino sugar as stabilizing agents of pharmaceutical agents containing G-CSF.
摘要:
The present invention relates to new amino alcohol derivatives, process for the production thereof and medicaments and reagents containing these compounds.
摘要:
Aqueous pharmaceutical preparations of G-CSF are disclosed that are stable on storage and a buffer selected from the group consisting of a salt of citrate, maleate, a combination of phosphate and citrate, and arginine; and at least one surfactant.
摘要:
The invention relates to a light plaster mixture in pasty form which has improved storage stability. This is based on a composition which contains a binder, inorganic fillers, light fillers, water and also further additives. The light plaster mixture according to the invention can be used in the form of final coats on any bases.
摘要:
In a process for the production of recombinant, biologically active, eukaryotic alkaline phosphatase a DNA sequence coding for a eukaryotic alkaline phosphatase is expressed in a prokaryotic host cell and the expression product is obtained in an active form by cell lysis, solubilization under denaturing conditions and subsequent renaturation. In this process the renaturation step is carried out in the presence of one or several stabilizing agents.
摘要:
The present invention relates to parvovirus mutated structural proteins comprising insertions of mimotopes of a HER2, compositions, multimeric structures, medicaments and vaccines comprising the same, nucleic acids, expression cassettes, constructs, vectors and cells comprising the nucleic acids, methods of preparing the structural proteins and methods of inducing a B-cell response or of treating a HER2-related disease.